Mostrar el registro sencillo

dc.contributor.authorComins Boo, Alejandra
dc.contributor.authorValdeolivas, Lorena
dc.contributor.authorPérez Pla, Fernando 
dc.contributor.authorCristóbal, Ignacio
dc.contributor.authorSubhi-Issa, Nabil
dc.contributor.authorDomínguez Soto, Ángeles
dc.contributor.authorPilar Suárez, Lydia
dc.contributor.authorGasca Escorial, Pilar
dc.contributor.authorCalvo Urrutia, Marta
dc.contributor.authorFernández Arquero, Miguel
dc.contributor.authorHerráiz Martínez, Miguel Ángel
dc.contributor.authorCorbí, Ángel Luis
dc.contributor.authorSánchez Ramón, Silvia
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-12-23T17:03:28Z
dc.date.available2024-01-01T00:43:18Z
dc.date.issued2022-12
dc.identifier.issn0165-0378
dc.identifier.issn1872-7603
dc.identifier.urihttps://hdl.handle.net/10902/27006
dc.description.abstractRecurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) are two well-defined clinical entities, but the role of the monocytes in their pathophysiology needs to be clarified. This study aimed to evaluate the role of the three monocyte subsets (classical, intermediate, and non-classical) and relevant cytokines/chemokines in a cohort of RPL and RIF women to better characterize a baseline proinflammatory profile that could define inflammatory pathophysiology in these two different conditions. We evaluated 108 non-pregnant women: 53 RPL, 24 RIF, and 31 fertile healthy controls (HC). Multiparametric flow cytometry was used to quantify the frequency of surface chemokine receptors (CCR2, CCR5, and CX3CR1) on the monocyte subsets. Cytokines were assessed in plasma samples using a multiplex assay. The CX3CR1+ and CCR5+ intermediate monocytes were significantly higher in RPL and RIF compared to HC. A significant positive correlation was observed between CX3CR1+ intermediate monocytes and IL-17A (P = .03, r = 0.43). The Boruta algorithm followed by a multivariate logistic regression model was used to select the most relevant variables that could help define RPL and RIF: in RPL were CX3CR1 non-classical monocytes, TGF-B1, and CCR5 intermediate monocytes; in RIF: CCR5 intermediate monocytes and TGF-B3. The combination of these variables could predict RPL and RIF with 90 % and 82 %, respectively. Our study suggests that a combination of specific blood monocyte subsets and cytokines could aid in identifying RPL and RIF women with a pro-inflammatory profile. These findings could provide a more integrated understanding of these pathologies. Further investigation and validation in independent cohorts are warranted.es_ES
dc.description.sponsorshipThe project received a research grant from the Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), awarded on the 2016 call under the Health Strategy Action 2016–2017, within the National Research Program oriented to Societal Challenges, within the Technical, Scientific and Innovation Research National Plan 2013–2016, with reference PI16/01428, and was co-supported by The European Regional Development Fund (ERDF).es_ES
dc.format.extent29 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rights© 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of Reproductive Immunology, 2022, 154, 103735es_ES
dc.subject.otherRecurrent pregnancy losses_ES
dc.subject.otherRecurrent implantation failurees_ES
dc.subject.otherMonocyteses_ES
dc.subject.otherCCR5es_ES
dc.subject.otherCX3CR1es_ES
dc.titleImmunophenotyping of peripheral blood monocytes could help identify a baseline pro-inflammatory profile in women with recurrent reproductive failurees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1016/j.jri.2022.103735es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.jri.2022.103735
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 licenseExcepto si se señala otra cosa, la licencia del ítem se describe como © 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license